Bolin T D, Davis A E, Billington B
J Clin Gastroenterol. 1987 Jun;9(3):310-3. doi: 10.1097/00004836-198706000-00013.
We compared ranitidine and cimetidine in maintenance therapy to prevent duodenal ulcer recurrence over a period of 24 months. Endoscopic examination at the end of 12 months showed that the ulcers of 26 of 31 patients (84%) on ranitidine in a dose of 150 mg remained healed and of 10 of 13 (77%) patients on cimetidine in a dose of 400 mg at night remained healed. Thirty-four patients continued in an open evaluation of ranitidine in a dose of 150 mg at night for a further 12-month period, and during this time there were four further recurrences. Life table estimates of duodenal ulcer recurrence during the 2-year period showed no significant difference between the two forms of treatment.
我们比较了雷尼替丁和西咪替丁在维持治疗中预防十二指肠溃疡复发的效果,为期24个月。12个月末的内镜检查显示,31例服用150毫克雷尼替丁的患者中有26例(84%)溃疡仍愈合良好,13例每晚服用400毫克西咪替丁的患者中有10例(77%)溃疡仍愈合良好。34例患者继续接受每晚150毫克雷尼替丁的开放评估,为期12个月,在此期间又有4例复发。两年期间十二指肠溃疡复发的生命表估计显示,两种治疗方式之间无显著差异。